top of page

Biobeat has been approved by Invima Colombia

Updated: Oct 16, 2023

Biobeat has achieved a significant milestone by obtaining Invima approval for the use of its wrist and chest monitors in Colombia. This achievement allows Biobeat, in collaboration with partner Fundación Clínica Shaio, to extend its cutting-edge monitoring solutions to the Colombian population, ensuring enhanced healthcare services. The approval highlights Biobeat's commitment to global market expansion and signifies the growing recognition of its innovative monitoring technology.

The wrist and chest monitors offer a user-friendly and non-invasive means of tracking vital signs, facilitating improved patient care. The collaboration with Fundación Clínica Shaio underscores the practical application of Biobeat's solutions in real healthcare settings. This partnership enables the integration of Biobeat's advanced monitoring capabilities into the clinical practices of Fundación Clínica Shaio, contributing to more precise and comprehensive patient monitoring.

Overall, this achievement not only marks a remarkable step forward for Biobeat but also holds promise for advancing healthcare in Colombia. By making their monitoring technology accessible, Biobeat and Fundación Clínica Shaio are aligning with a shared mission to provide the best possible care to the population, exemplifying the positive impact of innovative medical solutions on a global scale.



bottom of page